text
stringlengths 0
146
|
|---|
required balloon dilation or
|
stenting of the bile ducts.
|
Biliary tract sclerosis or
|
obstruction as a
|
consequence of biliary
|
surgery, gall stone
|
disease, infection,
|
inflammatory bowel
|
disease or other
|
secondary precipitants is
|
excluded.
|
Cardiac Defibrillator
|
Insertion
|
Insertion of a permanent
|
cardiac defibrillator as a
|
result of cardiac
|
arrhythmia which cannot
|
be treated via any other
|
method. The surgical
|
procedure must be
|
certified to be absolutely
|
necessary by a specialist
|
in the relevant field.
|
Early Cardiomyopathy
|
The unequivocal
|
diagnosis of
|
cardiomyopathy which has
|
resulted in the presence of
|
permanent physical
|
impairments to at least
|
Class III of the New York
|
Heart Association (NYHA)
|
classification of Cardiac
|
Impairment.
|
The diagnosis must be
|
confirmed by a specialist
|
in the relevant field.
|
Cardiomyopathy that is
|
directly related to alcohol
|
misuse is excluded.
|
The NYHA Classification
|
of Cardiac Impairment
|
(Source: “Current Medical
|
Advanced Stage1
|
Fulminant Hepatitis
|
A submassive to massive
|
necrosis of the liver by the
|
Hepatitis virus, leading
|
precipitously to liver
|
failure.
|
This diagnosis must be
|
supported by all of the
|
following:
|
• Rapid decreasing of
|
liver size as confirmed
|
by abdominal
|
ultrasound;
|
• Necrosis involving entire
|
lobules, leaving only a
|
collapsed reticular
|
framework;
|
• Rapid deterioration of
|
liver function tests;
|
• Deepening jaundice;
|
and
|
• Hepatic
|
encephalopathy.
|
Heart Attack of Specified
|
Severity
|
Death of heart muscle due
|
to ischaemia, that is
|
evident by at least three of
|
the following criteria
|
proving the occurrence of
|
a new heart attack:
|
• History of typical chest
|
pain;
|
• New characteristic
|
electrocardiographic
|
changes; with the
|
development of any of
|
the following: ST
|
elevation or depression,
|
T wave inversion,
|
pathological Q waves or
|
left bundle branch block;
|
• Elevation of the cardiac
|
biomarkers, inclusive of
|
CKMB above the
|
generally accepted
|
normal laboratory levels
|
or Cardiac Troponin T or
|
I at 0.5ng/ml and above;
|
• Imaging evidence of new
|
loss of viable
|
myocardium or new
|
regional wall motion
|
abnormality. The
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.